Everolimus Added to Exemestane Reduced Bone Markers and Disease Progression in Bone in Postmenopausal Women with Advanced Breast Cancer: Updated Results From the BOLERO-2 Trial Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Gnant, M
  • Hortobagyi, GN
  • Rugo, H
  • Burris, HA
  • Noguchi, S
  • Pritchard, Kathleen
  • Baselga, J
  • Sahmoud, T
  • Bauly, H
  • Piccart, M

publication date

  • March 1, 2012